Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGO4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | C2CD4C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | LAMB2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | PLD2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | PKIB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | MIB1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | STARD7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | TXNDC16 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | EIF2B5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | CASD1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |